528 related articles for article (PubMed ID: 7819935)
1. Role of glycaemic control in development of microalbuminuria in patients with insulin dependent diabetes.
Powrie JK; Watts GF; Ingham JN; Taub NA; Talmud PJ; Shaw KM
BMJ; 1994 Dec; 309(6969):1608-12. PubMed ID: 7819935
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for development of microalbuminuria in insulin dependent diabetic patients: a cohort study. Microalbuminuria Collaborative Study Group, United Kingdom.
BMJ; 1993 May; 306(6887):1235-9. PubMed ID: 8499853
[TBL] [Abstract][Full Text] [Related]
3. Intensive therapy and progression to clinical albuminuria in patients with insulin dependent diabetes mellitus and microalbuminuria. Microalbuminuria Collaborative Study Group, United Kingdom.
BMJ; 1995 Oct; 311(7011):973-7. PubMed ID: 7580637
[TBL] [Abstract][Full Text] [Related]
4. The association between retinopathy, nephropathy, cardiovascular disease and long-term metabolic control in type 1 diabetes mellitus: a 5 year follow-up study of 442 adult patients in routine care.
Agardh CD; Agardh E; Torffvit O
Diabetes Res Clin Pract; 1997 Mar; 35(2-3):113-21. PubMed ID: 9179466
[TBL] [Abstract][Full Text] [Related]
5. Predictors of the development of microalbuminuria in patients with Type 1 diabetes mellitus: a seven-year prospective study. The Microalbuminuria Collaborative Study Group.
Diabet Med; 1999 Nov; 16(11):918-25. PubMed ID: 10588521
[TBL] [Abstract][Full Text] [Related]
6. The natural course of microalbuminuria in insulin-dependent diabetes: a 10-year prospective study.
Mathiesen ER; Rønn B; Storm B; Foght H; Deckert T
Diabet Med; 1995 Jun; 12(6):482-7. PubMed ID: 7648820
[TBL] [Abstract][Full Text] [Related]
7. Increase in serum prorenin precedes onset of microalbuminuria in patients with insulin-dependent diabetes mellitus.
Deinum J; Rønn B; Mathiesen E; Derkx FH; Hop WC; Schalekamp MA
Diabetologia; 1999 Aug; 42(8):1006-10. PubMed ID: 10491762
[TBL] [Abstract][Full Text] [Related]
8. Main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyperglycemia.
Ravid M; Brosh D; Ravid-Safran D; Levy Z; Rachmani R
Arch Intern Med; 1998 May; 158(9):998-1004. PubMed ID: 9588433
[TBL] [Abstract][Full Text] [Related]
9. Is a random urinary albumin concentration a useful screening test in insulin-treated diabetic patients?
Beatty OL; Ritchie CM; Hadden DR; Kennedy L; Bell PM; Atkinson AB
Ir J Med Sci; 1994 Sep; 163(9):406-9. PubMed ID: 7982765
[TBL] [Abstract][Full Text] [Related]
10. Effect of deletion polymorphism of angiotensin converting enzyme gene on progression of diabetic nephropathy during inhibition of angiotensin converting enzyme: observational follow up study.
Parving HH; Jacobsen P; Tarnow L; Rossing P; Lecerf L; Poirier O; Cambien F
BMJ; 1996 Sep; 313(7057):591-4. PubMed ID: 8806248
[TBL] [Abstract][Full Text] [Related]
11. The determinants of early nephropathy in insulin-dependent diabetes mellitus: a prospective study based on the urinary excretion of albumin.
Watts GF; Harris R; Shaw KM
Q J Med; 1991 Apr; 79(288):365-78. PubMed ID: 1852860
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for development of incipient and overt diabetic nephropathy in patients with non-insulin dependent diabetes mellitus: prospective, observational study.
Gall MA; Hougaard P; Borch-Johnsen K; Parving HH
BMJ; 1997 Mar; 314(7083):783-8. PubMed ID: 9080995
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of angiotensin-I converting enzyme I/D polymorphism for nephropathy in type 1 diabetes mellitus: a prospective study.
Hadjadj S; Belloum R; Bouhanick B; Gallois Y; Guilloteau G; Chatellier G; Alhenc-Gelas F; Marre M
J Am Soc Nephrol; 2001 Mar; 12(3):541-549. PubMed ID: 11181802
[TBL] [Abstract][Full Text] [Related]
14. Predictors of mortality in insulin dependent diabetes: 10 year observational follow up study.
Rossing P; Hougaard P; Borch-Johnsen K; Parving HH
BMJ; 1996 Sep; 313(7060):779-84. PubMed ID: 8842069
[TBL] [Abstract][Full Text] [Related]
15. Lack of synergism between long-term poor glycaemic control and three gene polymorphisms of the renin angiotensin system on risk of developing diabetic nephropathy in type I diabetic patients.
Tarnow L; Kjeld T; Knudsen E; Major-Pedersen A; Parving HH
Diabetologia; 2000 Jun; 43(6):794-9. PubMed ID: 10907125
[TBL] [Abstract][Full Text] [Related]
16. Arterial hypertension and microalbuminuria in IDDM: the Italian Microalbuminuria Study.
Mangili R; Deferrari G; Di Mario U; Giampietro O; Navalesi R; Nosadini R; Rigamonti G; Spezia R; Crepaldi G
Diabetologia; 1994 Oct; 37(10):1015-24. PubMed ID: 7851680
[TBL] [Abstract][Full Text] [Related]
17. Increased plasma metalloproteinase-9 concentrations precede development of microalbuminuria in non-insulin-dependent diabetes mellitus.
Ebihara I; Nakamura T; Shimada N; Koide H
Am J Kidney Dis; 1998 Oct; 32(4):544-50. PubMed ID: 9774113
[TBL] [Abstract][Full Text] [Related]
18. The relationship between the development and progression of microalbuminuria and arterial blood pressure in type 1 (insulin-dependent) diabetes mellitus.
Raal FJ; Kalk WJ; Taylor DR; Osler CE; Panz VR
Diabetes Res Clin Pract; 1992 Jun; 16(3):221-7. PubMed ID: 1425143
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for development of incipient and overt diabetic nephropathy in type 1 diabetic patients: a 10-year prospective observational study.
Rossing P; Hougaard P; Parving HH
Diabetes Care; 2002 May; 25(5):859-64. PubMed ID: 11978681
[TBL] [Abstract][Full Text] [Related]
20. Captopril reduces the risk of nephropathy in IDDM patients with microalbuminuria. The Microalbuminuria Captopril Study Group.
Diabetologia; 1996 May; 39(5):587-93. PubMed ID: 8739919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
